Author:
Casale Thomas B.,Murphy Thomas R.,Holden Michael,Rajput Yamina,Yoo Bongin,Bernstein Jonathan A.
Funder
Novartis Pharmaceuticals Corporation
Novartis
CSL Behring
Teva Pharmaceutical Industries
BioCryst
AstraZeneca
Genentech
Shire
Reference9 articles.
1. The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria;Engin;J Eur Acad Dermatol Venereol,2008
2. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU;Maurer;Allergy,2017
3. The impact of chronic urticaria on the quality of life;O’Donnell;Br J Dermatol,1997
4. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria: the 2017 revision and update;Zuberbier;Allergy,2018
5. Unmet clinical needs in chronic spontaneous urticaria: a GA2LEN task force report;Maurer;Allergy,2011
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献